A short clinical review of vaccination against measles

JRSM Short Reports

Volumn 5, Issue 4, 2014, Pages 1-6

  Tannous, Leen Khader ^a   Barlow, Gavin ^a,b   Metcalfe, Neil H ^c  

^a UNIVERSITY OF HULL   (United Kingdom)

^b HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

^c Axon Nidd Park House   (United Kingdom)

Author keywords

Measles; Vaccination; Vaccine

Indexed keywords

MEASLES VACCINE;

CLINICAL FEATURE; DISEASE TRANSMISSION; HEALTH EDUCATION; HEALTH PERSONNEL ATTITUDE; IMMUNITY; MEASLES; MORBIDITY; MORTALITY; MUMPS; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; REVIEW; RISK FACTOR; RUBELLA; STATISTICAL ANALYSIS; VACCINATION;

EID: 84922978075     PISSN: None     EISSN: 20425333     Source Type: Journal    
DOI: 10.1177/2054270414523408     Document Type: Review

References (27)

1. Wakefield A. New Evidence Refutes Fraud Findings in Dr. Wakefield Case. Interviewed by Mercola JM. See http://articles.mercola.com/sites/articles/archive/2012/ 01/24/new-evidence-refutes-fraud-findings-in-dr-wakefield-case.aspx (2012, last checked 14 October 2013).
2. World Health Organization. Measles. Fact sheet No 286. See http://www.who.int/mediacentre/factsheets/ fs286/en/ (2012, last checked 14 October 2013).
3. Miller CL. Severity of notified measles. Br Med J 1978; 1: 1253-1255.
4. World Health Organization. Measles and Rubella Surveillance and Outbreak Investigation Guidelines. See http://www.searo.who.int/LinkFiles/Measles_and_MNT_ SEA_Regional_Guidelines_M&R_Surveillance_and_ Outbreak_Investigation.pdf (2009, last checked 14 October 2013).
5. Baxi R, Mytton OT, Abid M, et al. Outbreak report: nosocomial transmission of measles though an unvaccinated healthcare worker-implications for public health. J Public Health Epub ahead of print 6 October 2013. DOI: 10.1093/pubmed/fdt096.
6. Bannaga AS, Wiles S, Rahama O, et al. Study in pink. . . rash!. BMJ Case Rep 2013. DOI: 10.1136/bcr-2013-201319.
7. Health Protection Agency. Measles Notifications and Deaths in England and Wales, 1940-2008. See http:// www.hpa.org.uk/web/HPAweb&HPAwebStandard/ HPAweb_C/1195733835814 (2013, last checked 14 October 2013).
8. Goffe AP and Laurence GD. Vaccination against measles: Part I. Preparation and testing of vaccines consisting of live attenuated virus. BMJ 1962; 2: 1244-1246.
9. Aldous IR, Kirman H, Butler N, Goffe AP, Laurence GD and Pollock TM. Vaccination against measles: Part III. Clinical trial in British children. BMJ 1961; 2: 1250-1253.
10. Benson PF, Butler NR, Goffe AP, et al. Vaccination of infants with living attenuated measles vaccine (Edmonston strain) with and without gamma-globulin. BMJ 1964; 2: 851-853.
11. Ramsay M, Gay N, Miller E, et al. The Epidemiology of Measles in England and Wales: Rationale for the 1994 National Vaccination Campaign. Health Protection Agency. Report number 12, 1994.
12. Medical Research Council. Measles. See http:// www.mrc.ac.uk/Achievementsimpact/Storiesofimpact/ Measles/index.htm (last checked October 2013).
13. Krugman S. Present status of measles and rubella immunization in the United States: a medical progress report. J Pediatr 1971; 78: 1-16.
14. Health Protection Agency. Completed Primary Courses at Two Years of Age: England and Wales, 1966-1977, England only 1978 onwards. See http://www.hpa.org. uk/web/HPAweb&HPAwebStandard/HPAweb_C/ 1195733819251 (2011, last checked 14 October 2013).
15. Health Protection Agency. Herd Immunity-Concepts of Control. See www.hpa.org.uk/webc/HPAwebFile/ HPAweb_C/1279889319696 (last checked 14 October 2013).
16. Wakefield AJ, Pittilo RM, Sim R, et al. Evidence of persistent measles virus infection in Crohn's disease. J Med Virol 1993; 39: 345-353.
17. Wakefield AJ, Murch SH, Anthony A, et al. Ileallymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. The Lancet 1998; 351: 637-641.
18. Deer B. How the vaccine crisis was meant to make money. BMJ 2011; 342: 136-142.
19. British United Provident Association. Measles, Mumps and Rubella (MMR) Vaccine. See http://www.bupa. co.uk/individuals/health-information/directory/m/ mmr-vaccine (2011, last checked 14 October 2013).
20. Health Protection Agency. Confirmed Cases of Measles, Mumps and Rubella 1996-2011. See http:// www.hpa.org.uk/web/HPAweb&HPAwebStandard/ HPAweb_C/1195733833790 (2013, last checked 14 October 2013).
21. Health Protection Agency. Vaccine Uptake at All Time High on Merseyside. See http://www.hpa.org.uk/ ProductsServices/LocalServices/NorthWest/North WestPressReleases/nwest120613merseysidemeaslesvacc/ (last checked 14 October 2013).
22. Health Protection Agency. Number of Laboratory Confirmed Measles Cases in England and Wales. See http://www.hpa.org.uk/web/HPAweb&HPAweb Standard/HPAweb_C/1223019390211 (2013, last checked 14 October 2013).
23. BBC News. Swansea Measles Epidemic Officially Over. See http://www.bbc.co.uk/news/uk-wales-23168519 (2013, last checked 13 January 2014).
24. Brown KF, Long SJ, Ramsay M, et al. UK parents' decision-making about measles-mumps-rubella (MMR) vaccine 10 years after the MMR-autism controversy: a qualitative analysis. J Vaccine 2012; 30: 1855-1864.
25. Shourie S, Jackson C, Cheater FM, et al. A cluster randomized controlled trial of a web based decision aid to support parents' decision about their child's Measles Mumps and Rubella (MMR) vaccination. J Vaccine 2013; 31: 6003-6010.
26. Chris TB and Samit B. Evolutionary game theory and social learning can determine how vaccine scares unfold. PLoS Comput Biol 2012; 8: e1002452.
27. Cockman P, Dawson L, Mathur R, et al. Improving MMR vaccination rates: herd immunity is a realistic goal. BMJ 2011; 343: d5703.